Incyte (INCY)
(Delayed Data from NSDQ)
$51.18 USD
-0.56 (-1.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $51.16 -0.02 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/30/2024
Time: BMO |
3/2024 | $0.88 | -3.55% |
Earnings Summary
For their last quarter, Incyte (INCY) reported earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.21 per share. This reflects a negative earnings surprise of 12.40%. Look out for INCY's next earnings release on April 30, 2024. For the next earning release, we expect the company to report earnings of $0.88 per share, reflecting a year-over-year increase of 137.84%.
Earnings History
Price & Consensus
Zacks News for INCY
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
INCY: What are Zacks experts saying now?
Zacks Private Portfolio Services